Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Hackney

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Cell|January 25, 2020
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe AsthmaHenry R Maun, Janet K Jackman, David F Choy, et al.
Cell|October 5, 2019
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe AsthmaHenry R Maun, Janet K Jackman, David F Choy, et al.
Nature Medicine|February 22, 2022
Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activityMathieu Uzzan, Jerome C Martin, Luka Mesin, et al.
Iscience|October 9, 2023
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signalingJason A Hackney, Haridha Shivram, Jason Vander Heiden, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Cell|January 25, 2020
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe AsthmaHenry R Maun, Janet K Jackman, David F Choy, et al.
Cell|October 5, 2019
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe AsthmaHenry R Maun, Janet K Jackman, David F Choy, et al.
Nature Medicine|February 22, 2022
Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activityMathieu Uzzan, Jerome C Martin, Luka Mesin, et al.
Iscience|October 9, 2023
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signalingJason A Hackney, Haridha Shivram, Jason Vander Heiden, et al.
Pageof 6